Aoyama N - Search Results

1

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.

Miki I, Aoyama N, Sakai T, Shirasaka D, Wambura CM, Maekawa S, Kuroda K, Tamura T, Kita T, Sakaeda T, Okumura K, Kasuga M. Miki I, et al. Among authors: aoyama n. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):27-33. doi: 10.1097/00042737-200301000-00006. Eur J Gastroenterol Hepatol. 2003. PMID: 12544691 Clinical Trial.

2

[Progress of tailor-made treatment of peptic ulcer].

Aoyama N, Shirasaka D, Okumura K. Aoyama N, et al. Nihon Rinsho. 2002 Jan;60(1):174-81. Nihon Rinsho. 2002. PMID: 11808330 Review. Japanese.

3

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.

Kita T, Sakaeda T, Aoyama N, Sakai T, Kawahara Y, Kasuga M, Okumura K. Kita T, et al. Among authors: aoyama n. Biol Pharm Bull. 2002 Jul;25(7):923-7. doi: 10.1248/bpb.25.923. Biol Pharm Bull. 2002. PMID: 12132671 Free article.

4

[Tailor-made medicine in Helicobacter pylori eradication therapy].

Aoyama N, Shirasaka D, Miki I. Aoyama N, et al. Nihon Rinsho. 2003 Jan;61(1):129-36. Nihon Rinsho. 2003. PMID: 12607330 Review. Japanese.

5

Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors.

Kita T, Sakaeda T, Baba T, Aoyama N, Kakumoto M, Kurimoto Y, Kawahara Y, Okamura N, Kirita S, Kasuga M, Okumura K. Kita T, et al. Among authors: aoyama n. Biol Pharm Bull. 2003 Mar;26(3):386-90. doi: 10.1248/bpb.26.386. Biol Pharm Bull. 2003. PMID: 12612455 Free article.

6

Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.

Wambura C, Aoyama N, Shirasaka D, Kuroda K, Maekawa S, Ebara S, Watanabe Y, Tamura T, Kasuga M. Wambura C, et al. Among authors: aoyama n. Eur J Gastroenterol Hepatol. 2004 Oct;16(10):969-79. doi: 10.1097/00042737-200410000-00004. Eur J Gastroenterol Hepatol. 2004. PMID: 15371919

7

Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.

Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M. Nishioka C, et al. Among authors: aoyama n. J Gastroenterol Hepatol. 2005 Oct;20(10):1567-71. doi: 10.1111/j.1440-1746.2005.03907.x. J Gastroenterol Hepatol. 2005. PMID: 16174075 Clinical Trial.

8

[Recent trends in first-line therapy for H. pylori infection in the world].

Miki I, Shirasaka D, Morita Y, Aoyama N. Miki I, et al. Among authors: aoyama n. Nihon Rinsho. 2005 Nov;63 Suppl 11:418-20. Nihon Rinsho. 2005. PMID: 16363571 Review. Japanese. No abstract available.

9

HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection.

Watanabe Y, Aoyama N, Sakai T, Shirasaka D, Maekawa S, Kuroda K, Wambura C, Tamura T, Nose Y, Kasuga M. Watanabe Y, et al. Among authors: aoyama n. J Gastroenterol Hepatol. 2006 Feb;21(2):420-4. doi: 10.1111/j.1440-1746.2005.04112.x. J Gastroenterol Hepatol. 2006. PMID: 16509868

10

Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the 13C-octanoic acid breath test and the acetaminophen method.

Kachi M, Shirasaka D, Aoyama N, Ebara S, Miki I, Morita Y, Tamura T, Kasuga M. Kachi M, et al. Among authors: aoyama n. J Gastroenterol Hepatol. 2006 May;21(5):824-30. doi: 10.1111/j.1440-1746.2006.04075.x. J Gastroenterol Hepatol. 2006. PMID: 16704530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page